{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:05:37Z","timestamp":1784196337350,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05081-9","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T05:40:03Z","timestamp":1772948403000},"page":"2863-2870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bladder cancer organoids: bridging pathological features and drug response for precision oncology"],"prefix":"10.1007","volume":"58","author":[{"given":"Qiaoli","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"issue":"6194","key":"5081_CR1","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA (2014) Organogenesis in a dish: modeling development and disease using organoid technologies. Science (New York, NY) 345(6194):1247125. https:\/\/doi.org\/10.1126\/science.1247125","journal-title":"Science (New York, NY)"},{"issue":"1","key":"5081_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 70(1):106\u2013119. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028","journal-title":"Eur Urol"},{"issue":"1","key":"5081_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.eururo.2018.09.003","volume":"75","author":"JI Warrick","year":"2019","unstructured":"Warrick JI, Sj\u00f6dahl G, Kaag M, Raman JD, Merrill S, Shuman L, Chen G, Walter V, DeGraff DJ (2019) Intratumoral heterogeneity of bladder cancer by molecular subtypes and histologic variants. Eur Urol 75(1):18\u201322. https:\/\/doi.org\/10.1016\/j.eururo.2018.09.003","journal-title":"Eur Urol"},{"issue":"4","key":"5081_CR4","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y, Sj\u00f6dahl G, Robertson AG, Seiler R, Hoadley KA, Groeneveld CS, Al-Ahmadie H, Choi W, Castro MAA, Fontugne J, Eriksson P, Mo Q, Kardos J, Zlotta A, Hartmann A, Dinney CP, Bellmunt J, Powles T, Malats N, Chan KS, Kim WY, McConkey DJ, Black PC, Dyrskj\u00f8t L, H\u00f6glund M, Lerner SP, Real FX, Radvanyi F (2020) A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 77(4):420\u2013433. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006","journal-title":"Eur Urol"},{"issue":"1","key":"5081_CR5","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41467-023-37696-2","volume":"14","author":"M Minoli","year":"2023","unstructured":"Minoli M, Cantore T, Hanhart D, Kiener M, Fedrizzi T, La Manna F, Karkampouna S, Chouvardas P, Genitsch V, Rodriguez-Calero A, Comp\u00e9rat E, Klima I, Gasperini P, Kiss B, Seiler R, Demichelis F, Thalmann GN, Kruithof-de Julio M (2023) Bladder cancer organoids as a functional system to model different disease stages and therapy response. Nat Commun 14(1):2214. https:\/\/doi.org\/10.1038\/s41467-023-37696-2","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"5081_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen MM, Ellis E, van Wenum M, Fuchs SA, de Ligt J, van de Wetering M, Sasaki N, Boers SJ, Kemperman H, de Jonge J, Ijzermans JN, Nieuwenhuis EE, Hoekstra R, Strom S, Vries RR, van der Laan LJ, Cuppen E, Clevers H (2015) Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160(1\u20132):299\u2013312. https:\/\/doi.org\/10.1016\/j.cell.2014.11.050","journal-title":"Cell"},{"key":"5081_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092062","author":"B Medle","year":"2022","unstructured":"Medle B, Sj\u00f6dahl G, Eriksson P, Liedberg F, H\u00f6glund M, Bernardo C (2022) Patient-Derived Bladder Cancer Organoid Models in Tumor Biology and Drug Testing: A Systematic Review. Cancers. https:\/\/doi.org\/10.3390\/cancers14092062","journal-title":"Cancers"},{"key":"5081_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1248","author":"L Yu","year":"2021","unstructured":"Yu L, Li Z, Mei H, Li W, Chen D, Liu L, Zhang Z, Sun Y, Song F, Chen W, Huang W (2021) Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro. Clin & Transl Immunol. https:\/\/doi.org\/10.1002\/cti2.1248","journal-title":"Clin & Transl Immunol"},{"key":"5081_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189454","author":"H Kang","year":"2025","unstructured":"Kang H, Liu X, Ge D, Zeng Y (2025) Revolutionizing bladder cancer research: harnessing 3D organoid technology to decode tumor heterogeneity and propel personalized therapeutics. Biochim et Biophys Acta (BBA) Rev Cancer. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189454","journal-title":"Biochim et Biophys Acta (BBA) Rev Cancer"},{"issue":"3","key":"5081_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41416-023-02494-6","volume":"130","author":"BJ Viergever","year":"2024","unstructured":"Viergever BJ, Raats DAE, Geurts V, Mullenders J, Jonges TN, van der Heijden MS, van Es JH, Kranenburg O, Meijer RP (2024) Urine-derived bladder cancer organoids (urinoids) as a tool for cancer longitudinal response monitoring and therapy adaptation. Br J Cancer 130(3):369\u2013379. https:\/\/doi.org\/10.1038\/s41416-023-02494-6","journal-title":"Br J Cancer"},{"key":"5081_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23136956","author":"L Becker","year":"2022","unstructured":"Becker L, Fischer F, Fleck J, Harland N, Herkommer A, Stenzl A, Aicher W, Schenke-Layland K, Marzi J (2022) Data-driven identification of biomarkers for in situ monitoring of drug treatment in bladder cancer organoids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23136956","journal-title":"Int J Mol Sci"},{"key":"5081_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217793","author":"R Yang","year":"2025","unstructured":"Yang R, Wang S, Li Z, Yin C, Huang W, Huang W (2025) Patient-derived organoid co-culture systems as next-generation models for bladder cancer stem cell research. Cancer Lett. https:\/\/doi.org\/10.1016\/j.canlet.2025.217793","journal-title":"Cancer Lett"},{"key":"5081_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01278-4","author":"H Xu","year":"2022","unstructured":"Xu H, Jiao D, Liu A, Wu K (2022) Tumor organoids: applications in cancer modeling and potentials in precision medicine. J hematol & oncol. https:\/\/doi.org\/10.1186\/s13045-022-01278-4","journal-title":"J hematol & oncol"},{"key":"5081_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076232","author":"J Neuhaus","year":"2023","unstructured":"Neuhaus J, Rabien A, Reinhold A, Koehler L, Berndt-Paetz M (2023) 3D tumor models in urology. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24076232","journal-title":"Int J Mol Sci"},{"key":"5081_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107668","author":"R Xu","year":"2020","unstructured":"Xu R, Zhou X, Wang S, Trinkle C (2020) Tumor organoid models in precision medicine and investigating cancer-stromal interactions. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107668","journal-title":"Pharmacol Ther"},{"issue":"10","key":"5081_CR16","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1073\/pnas.1803595116","volume":"116","author":"J Mullenders","year":"2019","unstructured":"Mullenders J, de Jongh E, Brousali A, Roosen M, Blom JPA, Begthel H, Korving J, Jonges T, Kranenburg O, Meijer R, Clevers HC (2019) Mouse and human urothelial cancer organoids: a tool for bladder cancer research. Proc Natl Acad Sci U S A 116(10):4567\u20134574. https:\/\/doi.org\/10.1073\/pnas.1803595116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5081_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1248","volume":"10","author":"L Yu","year":"2021","unstructured":"Yu L, Li Z, Mei H, Li W, Chen D, Liu L, Zhang Z, Sun Y, Song F, Chen W, Huang W (2021) Patient-derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR-T cells in vitro. Clin Transl Immunol 10(2):e1248. https:\/\/doi.org\/10.1002\/cti2.1248","journal-title":"Clin Transl Immunol"},{"issue":"1","key":"5081_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00466-w","volume":"7","author":"M Garioni","year":"2023","unstructured":"Garioni M, Tschan VJ, Blukacz L, Nuciforo S, Parmentier R, Roma L, Coto-Llerena M, Pueschel H, Piscuoglio S, Vlajnic T, Stenner F, Seifert HH, Rentsch CA, Bubendorf L, Le Magnen C (2023) Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer. npj Precis Oncol 7(1):112. https:\/\/doi.org\/10.1038\/s41698-023-00466-w","journal-title":"npj Precis Oncol"},{"key":"5081_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11112958","author":"M Berndt-Paetz","year":"2023","unstructured":"Berndt-Paetz M, Han S, Weimann A, Reinhold A, N\u00fcrnberger S, Neuhaus J (2023) Cell line-based human bladder organoids with bladder-like self-organization-a new standardized approach in bladder cancer research. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11112958","journal-title":"Biomedicines"},{"issue":"7839","key":"5081_CR20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41586-020-3034-x","volume":"588","author":"E Kim","year":"2020","unstructured":"Kim E, Choi S, Kang B, Kong J, Kim Y, Yoon WH, Lee HR, Kim S, Kim HM, Lee H, Yang C, Lee YJ, Kang M, Roh TY, Jung S, Kim S, Ku JH, Shin K (2020) Creation of bladder assembloids mimicking tissue regeneration and cancer. Nature 588(7839):664\u2013669. https:\/\/doi.org\/10.1038\/s41586-020-3034-x","journal-title":"Nature"},{"issue":"9","key":"5081_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202317613","volume":"63","author":"Z Zhao","year":"2024","unstructured":"Zhao Z, Zhang S, Jiang N, Zhu W, Song D, Liu S, Yu W, Bai Y, Zhang Y, Wang X, Zhong X, Guo H, Guo Z, Yang R, Li JP (2024) Patient-derived immunocompetent tumor organoids: a platform for chemotherapy evaluation in the context of T-cell recognition. Angew Chem Int Ed Engl 63(9):e202317613. https:\/\/doi.org\/10.1002\/anie.202317613","journal-title":"Angew Chem Int Ed Engl"},{"issue":"2","key":"5081_CR22","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB, Bergren SK, Pietzak EJ, Anderson CB, Benson MC, Coleman JA, Taylor BS, Abate-Shen C, McKiernan JM, Al-Ahmadie H, Solit DB, Shen MM (2018) Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173(2):515\u2013528. https:\/\/doi.org\/10.1016\/j.cell.2018.03.017","journal-title":"Cell"},{"key":"5081_CR23","volume-title":"Clinical cancer research","author":"C Le Coz","year":"2024","unstructured":"Le Coz C, Christin JR, Syed T, Wang Z, Laplaca CJ, Lenis AT, Shen MM (2024) Luminal-to-basal phenotypic plasticity promotes invasive phenotypes in a liveimaging assay using patient-derived bladder tumor organoids. Clinical cancer research, vol 10. Amer ASSOC Cancer Research, Philadelphia"},{"issue":"6","key":"5081_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189199","volume":"1879","author":"Z Guo","year":"2024","unstructured":"Guo Z, Li Z, Wang J, Jiang H, Wang X, Sun Y, Huang W (2024) Modeling bladder cancer in the laboratory: insights from patient-derived organoids. Biochim Biophys Acta Rev Cancer 1879(6):189199. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189199","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"5081_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16162-3","volume":"11","author":"JP Sfakianos","year":"2020","unstructured":"Sfakianos JP, Daza J, Hu Y, Anastos H, Bryant G, Bareja R, Badani KK, Galsky MD, Elemento O, Faltas BM, Mulholland DJ (2020) Epithelial plasticity can generate multi-lineage phenotypes in human and murine bladder cancers. Nat Commun 11(1):2540. https:\/\/doi.org\/10.1038\/s41467-020-16162-3","journal-title":"Nat Commun"},{"key":"5081_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202414558","author":"H Zhao","year":"2025","unstructured":"Zhao H, Lin N, Ho VW-S, Liu K, Chen X, Wu H, Chiu P, Huang L, Dantes Z, Wong KL, Chau HF, Ko I, Wong C, Leung D, Yuen S, Wu D, Ding X, Ng C, Teoh J (2025) patient-derived bladder cancer organoids as a valuable tool for understanding tumor biology and developing personalized treatment. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202414558","journal-title":"Adv Sci"},{"issue":"19","key":"5081_CR27","doi-asserted-by":"publisher","first-page":"5894","DOI":"10.1158\/0008-5472.Can-16-0436","volume":"76","author":"P Lamy","year":"2016","unstructured":"Lamy P, Nordentoft I, Birkenkamp-Demtr\u00f6der K, Thomsen MB, Villesen P, Vang S, Hedegaard J, Borre M, Jensen JB, H\u00f8yer S, Pedersen JS, \u00d8rntoft TF, Dyrskj\u00f8t L (2016) Paired exome analysis reveals clonal evolution and potential therapeutic targets in urothelial carcinoma. Cancer Res 76(19):5894\u20135906. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-0436","journal-title":"Cancer Res"},{"issue":"1","key":"5081_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12894-023-01262-1","volume":"23","author":"R Seiler","year":"2023","unstructured":"Seiler R, Egger M, De Menna M, Wehrli S, Minoli M, Radi\u0107 M, Lyatoshinsky P, H\u00f6sli R, Blarer J, Abt D, Kruithof-de Julio M (2023) Guidance of adjuvant instillation in intermediate-risk non-muscle invasive bladder cancer by drug screens in patient derived organoids: a single center, open-label, phase II trial. BMC Urol 23(1):89. https:\/\/doi.org\/10.1186\/s12894-023-01262-1","journal-title":"BMC Urol"},{"key":"5081_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116305","author":"Y Wei","year":"2022","unstructured":"Wei Y, Amend B, Todenh\u00f6fer T, Lipke N, Aicher WK, Fend F, Stenzl A, Harland N (2022) Urinary tract tumor organoids reveal eminent differences in drug sensitivities when compared to 2-dimensional culture systems. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23116305","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5081_CR30","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.euf.2024.08.008","volume":"11","author":"M Radi\u0107","year":"2025","unstructured":"Radi\u0107 M, Egger M, Kruithof-de Julio M, Seiler R (2025) Patient-derived organoids in bladder cancer: opportunities and challenges. Eur Urol Focus 11(1):62\u201370. https:\/\/doi.org\/10.1016\/j.euf.2024.08.008","journal-title":"Eur Urol Focus"},{"issue":"6","key":"5081_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin M, Joshi M, Meijer RP, Glantz M, Holder S, Harvey HA, Kaag M, Fransen van de Putte EE, Horenblas S, Drabick JJ (2016) Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist 21(6):708\u2013715. https:\/\/doi.org\/10.1634\/theoncologist.2015-0440","journal-title":"Oncologist"},{"issue":"32","key":"5081_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302377","volume":"10","author":"X Hong","year":"2023","unstructured":"Hong X, Chen X, Wang H, Xu Q, Xiao K, Zhang Y, Chi Z, Liu Y, Liu G, Li H, Fang J, Lin T, Zhang Y (2023) A HER2-targeted antibody-drug conjugate, RC48-ADC, exerted promising antitumor efficacy and safety with intravesical instillation in preclinical models of bladder cancer. Adv sci (Weinh, Baden-Wurtt, Ger) 10(32):e2302377. https:\/\/doi.org\/10.1002\/advs.202302377","journal-title":"Adv sci (Weinh, Baden-Wurtt, Ger)"},{"key":"5081_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100928","author":"TE Schnalzger","year":"2019","unstructured":"Schnalzger TE, de Groot MH, Zhang C, Mosa MH, Michels BE, R\u00f6der J, Darvishi T, Wels WS, Farin HF (2019) 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids. EMBO J. https:\/\/doi.org\/10.15252\/embj.2018100928","journal-title":"EMBO J"},{"issue":"8","key":"5081_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.it.2020.06.010","volume":"41","author":"K Yuki","year":"2020","unstructured":"Yuki K, Cheng N, Nakano M, Kuo CJ (2020) Organoid models of tumor immunology. Trends Immunol 41(8):652\u2013664. https:\/\/doi.org\/10.1016\/j.it.2020.06.010","journal-title":"Trends Immunol"},{"issue":"12","key":"5081_CR35","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1158\/0008-5472.Can-20-4026","volume":"81","author":"M Gr\u00f6nholm","year":"2021","unstructured":"Gr\u00f6nholm M, Feodoroff M, Antignani G, Martins B, Hamdan F, Cerullo V (2021) Patient-derived organoids for precision cancer immunotherapy. Cancer Res 81(12):3149\u20133155. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-4026","journal-title":"Cancer Res"},{"issue":"2","key":"5081_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2159-8290.Cd-17-0833","volume":"8","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Ca\u00f1adas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA (2018) Ex vivo profiling of PD-1 blockade using organotypic tumor spheroids. Cancer Discov 8(2):196\u2013215. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0833","journal-title":"Cancer Discov"},{"issue":"7","key":"5081_CR37","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, Liu IH, Chiou SH, Salahudeen AA, Smith AR, Deutsch BC, Liao L, Zemek AJ, Zhao F, Karlsson K, Schultz LM, Metzner TJ, Nadauld LD, Tseng YY, Alkhairy S, Oh C, Keskula P, Mendoza-Villanueva D, De La Vega FM, Kunz PL, Liao JC, Leppert JT, Sunwoo JB, Sabatti C, Boehm JS, Hahn WC, Zheng GXY, Davis MM, Kuo CJ (2018) Organoid modeling of the tumor immune microenvironment. Cell 175(7):1972\u20131988. https:\/\/doi.org\/10.1016\/j.cell.2018.11.021","journal-title":"Cell"},{"issue":"4","key":"5081_CR38","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/cu9.0000000000000219","volume":"17","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Sun X, Song X, Li Z, Zhang P, Zhang W, Tang D (2023) Patient-derived bladder cancer organoid model to predict sensitivity and feasibility of tailored precision therapy. Curr Urol 17(4):221\u2013228. https:\/\/doi.org\/10.1097\/cu9.0000000000000219","journal-title":"Curr Urol"},{"issue":"2","key":"5081_CR39","doi-asserted-by":"publisher","first-page":"235237352513304","DOI":"10.1177\/23523735251330404","volume":"11","author":"H Zhao","year":"2025","unstructured":"Zhao H, Ho VWS, Liu K, Chen X, Wu H, Chiu PK, Chan LY, Yuen SK, Leung DK, Liu AQ, Wong CH, Ko IC, Ng CF, Wu D, Teoh JY (2025) Organoid models in bladder cancer: from bench to bedside? Bladder cancer (Amst, Neth) 11(2):23523735251330404. https:\/\/doi.org\/10.1177\/23523735251330404","journal-title":"Bladder cancer (Amst, Neth)"},{"issue":"5","key":"5081_CR40","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.juro.2008.07.023","volume":"180","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, McNeill E, Tian H, Soker S, Andersson KE, Yoo JJ, Atala A (2008) Urine derived cells are a potential source for urological tissue reconstruction. J Urol 180(5):2226\u20132233. https:\/\/doi.org\/10.1016\/j.juro.2008.07.023","journal-title":"J Urol"},{"issue":"9","key":"5081_CR41","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/stem.1424","volume":"31","author":"S Bharadwaj","year":"2013","unstructured":"Bharadwaj S, Liu G, Shi Y, Wu R, Yang B, He T, Fan Y, Lu X, Zhou X, Liu H, Atala A, Rohozinski J, Zhang Y (2013) Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology. Stem Cells 31(9):1840\u20131856. https:\/\/doi.org\/10.1002\/stem.1424","journal-title":"Stem Cells"},{"key":"5081_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/cells12172188","author":"S Walz","year":"2023","unstructured":"Walz S, Pollehne P, Geng R, Schneider J, Maas M, Aicher WK, Stenzl A, Amend B, Harland N (2023) A protocol for organoids from the urine of bladder cancer patients. Cells. https:\/\/doi.org\/10.3390\/cells12172188","journal-title":"Cells"},{"issue":"1","key":"5081_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s44164-025-00086-7","volume":"4","author":"T Chauhdari","year":"2025","unstructured":"Chauhdari T, Zaidi SA, Su J, Ding Y (2025) Organoids meet microfluidics: recent advancements, challenges, and future of organoids-on-chip. In Vitro Model 4(1):71\u201388. https:\/\/doi.org\/10.1007\/s44164-025-00086-7","journal-title":"In Vitro Model"},{"key":"5081_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering11050476","author":"I Dasgupta","year":"2024","unstructured":"Dasgupta I, Rangineni DP, Abdelsaid H, Ma Y, Bhushan A (2024) Tiny organs, big impact: How microfluidic organ-on-chip technology is revolutionizing mucosal tissues and vasculature. Bioengineering. https:\/\/doi.org\/10.3390\/bioengineering11050476","journal-title":"Bioengineering"},{"key":"5081_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bioactmat.2023.01.016","volume":"25","author":"Y Hu","year":"2023","unstructured":"Hu Y, Zhang H, Wang S, Cao L, Zhou F, Jing Y, Su J (2023) Bone\/cartilage organoid on-chip: construction strategy and application. Bioact Mater 25:29\u201341. https:\/\/doi.org\/10.1016\/j.bioactmat.2023.01.016","journal-title":"Bioact Mater"},{"issue":"12","key":"5081_CR46","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1039\/d2lc01109c","volume":"23","author":"SY Tan","year":"2023","unstructured":"Tan SY, Feng X, Cheng LKW, Wu AR (2023) Vascularized human brain organoid on-chip. Lab Chip 23(12):2693\u20132709. https:\/\/doi.org\/10.1039\/d2lc01109c","journal-title":"Lab Chip"},{"key":"5081_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112301","author":"H Castiglione","year":"2022","unstructured":"Castiglione H, Vigneron PA, Baquerre C, Yates F, Rontard J, Honegger T (2022) Human brain organoids-on-chip: advances, challenges, and perspectives for preclinical applications. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics14112301","journal-title":"Pharmaceutics"},{"key":"5081_CR48","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/acf8fb","author":"MR Carvalho","year":"2023","unstructured":"Carvalho MR, Yan LP, Li B, Zhang CH, He YL, Reis RL, Oliveira JM (2023) Gastrointestinal organs and organoids-on-a-chip: advances and translation into the clinics. Biofabrication. https:\/\/doi.org\/10.1088\/1758-5090\/acf8fb","journal-title":"Biofabrication"},{"issue":"2","key":"5081_CR49","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1039\/d3lc00843f","volume":"24","author":"A Sharma","year":"2024","unstructured":"Sharma A, Jin L, Wang X, Wang YT, Stresser DM (2024) Developing an adult stem cell derived microphysiological intestinal system for predicting oral prodrug bioconversion and permeability in humans. Lab Chip 24(2):339\u2013355. https:\/\/doi.org\/10.1039\/d3lc00843f","journal-title":"Lab Chip"},{"key":"5081_CR50","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/ad5ac0","author":"KT Kroll","year":"2024","unstructured":"Kroll KT, Homan KA, Uzel SGM, Mata MM, Wolf KJ, Rubins JE, Lewis JA (2024) A perfusable, vascularized kidney organoid-on-chip model. Biofabrication. https:\/\/doi.org\/10.1088\/1758-5090\/ad5ac0","journal-title":"Biofabrication"},{"issue":"1","key":"5081_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s10544-016-0143-2","volume":"19","author":"A Choe","year":"2017","unstructured":"Choe A, Ha SK, Choi I, Choi N, Sung JH (2017) Microfluidic gut-liver chip for reproducing the first pass metabolism. Biomed Microdevices 19(1):4. https:\/\/doi.org\/10.1007\/s10544-016-0143-2","journal-title":"Biomed Microdevices"},{"issue":"8","key":"5081_CR52","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/17425255.2021.1908996","volume":"17","author":"JH Sung","year":"2021","unstructured":"Sung JH (2021) Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs. Expert Opin Drug Metab Toxicol 17(8):969\u2013986. https:\/\/doi.org\/10.1080\/17425255.2021.1908996","journal-title":"Expert Opin Drug Metab Toxicol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05081-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05081-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05081-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:18:45Z","timestamp":1784193525000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05081-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":52,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["5081"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05081-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"4 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there are no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}